Home/Auxetics/John McDermott

JM

John McDermott

Chairman

Therapeutic Areas

Venous Disease Post-thrombotic Syndrome

Auxetics Pipeline

Drug	Indication	Phase
Auxetic Venous Stent	Chronic venous outflow obstruction / Post-thrombotic Syndrome (PTS)	Pre-clinical

Leadership Team at Auxetics

Ramsey Al-Hakim, MD

CEO, Co-Founder

John Kaufman, MD

Khashayar Farsad, MD, PhD

Scientific Advisory Board Chair, Co-Founder

View full Auxetics profile